American Beverage Association’s Every Bottle Back Recycling Initiative
Inquiry finds trade group overstates environmental benefits of recycling program.
Combivent Respimat Asthma Inhalers
In May 2019, a class-action lawsuit was filed against Boehringer Ingelheim Pharmaceuticals for allegedly deceptively marketing that the Combivent Respimat asthma inhaler will provide 120 doses when, according to plaintiffs, the inhaler contains far fewer dosages, sometimes less than half the advertised amount. (Ignacuinos et al v. Boehringer Ingelheim Pharmaceuticals, Inc., Case No. 19-cv-672, D. Conn.)
The Latest
Hair-Raising Claims by Unilever’s Nutrafol Reported to Regulators
TINA.org files complaint with the FDA and FTC over company’s hair growth claims.
Consumer Alert: Hair Growth Products
Supplement and serum companies are targeting consumers experiencing hair loss.
CATrends: Marketing Claims for Products Containing PFAS
Class-action lawsuits target human and environmentally-friendly claims.
Happy Mammoth Hormone Harmony
We’ve got some sad news: This supplement company’s health claims violate the law.